Cancer genetics, inc (CGIX)
Balance Sheet / TTM
Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12
ASSETS
CURRENT ASSETS
Cash and cash equivalents

2,100

700

700

161

1,206

1,601

4,022

9,541

4,807

6,170

9,664

9,502

10,716

10,552

13,273

19,459

19,917

23,744

22,311

25,554

30,748

37,417

41,314

49,459

9,878

1,940

216

819

Accounts receivable

813

691

7,292

777

8,981

9,357

10,335

10,958

15,797

13,155

12,675

11,748

13,679

11,944

8,449

6,621

5,165

5,722

4,824

5,028

4,108

2,056

1,818

1,567

1,616

1,263

1,124

850

Earn-Out from siParadigm, current portion

693

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Note receivable from IDXG

6,795

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other current assets

1,030

536

2,344

553

2,928

3,245

2,622

2,707

2,881

2,544

2,018

2,174

2,185

1,970

1,823

2,118

1,540

1,629

1,149

1,173

1,161

1,219

929

864

713

689

598

489

Current assets of discontinuing operations

1,125

24,660

-

23,421

-

-

2,058

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total current assets

12,603

26,554

10,333

24,912

13,115

14,203

19,037

23,206

23,485

21,869

24,357

23,424

26,580

24,466

23,545

28,198

26,623

31,096

28,285

31,755

36,018

40,693

44,062

51,891

12,207

3,893

1,940

2,159

FIXED ASSETS, net of accumulated depreciation

671

634

3,821

497

4,499

4,742

4,876

5,550

6,009

4,724

4,778

4,738

4,912

5,372

5,870

6,069

3,778

3,888

4,045

4,310

4,338

1,476

1,311

1,264

810

856

899

964

OTHER ASSETS
Operating lease right-of-use assets

115

153

2,422

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Restricted cash

350

350

350

350

350

350

350

350

300

300

300

300

300

300

300

300

300

300

6,300

6,300

6,300

6,300

6,300

300

300

300

250

250

Earn-Out from siParadigm, less current portion

594

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loan guarantee and financing fees, net of accumulated amortization of 2014 $0; 2013 $517,500

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

310

621

892

-

1,907

Patents and other intangible assets, net of accumulated amortization

-

-

-

-

-

-

-

4,478

-

-

-

1,503

-

-

-

1,727

585

552

534

503

476

450

431

401

366

348

-

324

Patents and other intangible assets, net of accumulated amortization

3,021

3,126

3,917

3,349

4,121

4,276

4,375

-

8,356

1,400

1,451

-

1,594

1,639

1,679

-

-

-

-

-

-

-

-

-

-

-

-

-

Investment in joint venture

92

92

92

92

242

243

244

246

247

249

256

268

296

314

329

341

300

642

840

1,048

1,328

677

975

987

-

19

-

-

Other investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

Other investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

39

-

-

-

-

-

-

-

Goodwill

3,090

5,963

17,257

5,963

17,257

17,257

17,257

17,992

14,158

12,029

12,029

12,029

12,029

12,029

12,029

12,029

3,187

3,187

3,187

3,187

3,130

-

-

0

-

-

-

-

Deposit for acquisition

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

880

-

-

-

1

1

1

1

1

1

1

1

Other

300

243

300

243

301

300

305

399

1,415

378

194

172

112

115

217

220

324

160

1

2

-

-

-

-

-

-

-

-

Deferred offering costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

142

-

3,343

Loan guarantee and financing fees, net of accumulated amortization of 2013 $1,334,610; 2012 $929,498

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,516

-

Patents

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

329

-

Deferred initial public offering costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,473

-

Total other assets

7,562

9,927

24,338

9,997

22,271

22,426

22,531

23,465

24,476

14,356

14,230

14,272

14,331

14,397

14,554

14,617

5,577

4,843

10,863

11,040

11,276

7,429

7,709

2,001

1,288

1,705

4,571

5,827

Total Assets

20,836

37,115

38,492

35,406

39,885

41,371

46,444

52,221

53,970

40,949

43,365

42,434

45,823

44,235

43,969

48,884

35,979

39,827

43,194

47,105

51,633

49,599

53,083

55,157

14,306

6,455

7,410

8,951

LIABILITIES AND STOCKHOLDERS’ EQUITY
CURRENT LIABILITIES
Accounts payable and accrued expenses

3,330

2,777

11,561

3,100

13,040

9,778

8,921

8,715

9,314

6,716

8,099

8,148

8,341

7,632

7,775

7,579

4,437

4,056

3,753

3,763

4,564

2,283

2,327

2,346

1,807

2,743

4,885

4,578

Obligations under operating leases, current portion

207

207

1,086

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Obligations under finance leases, current portion

60

36

321

-

-

-

-

272

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Obligations under finance leases, current portion

-

-

-

20

324

322

319

-

271

262

229

109

69

72

106

122

61

60

59

59

57

57

43

51

11

16

20

17

Deferred revenue

1,607

1,622

2,604

1,215

2,409

2,004

-

516

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

-

-

-

-

-

-

1,751

-

109

133

432

789

210

423

630

831

1,173

381

267

544

384

31

86

199

215

318

676

468

Notes payable, current portion

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

280

0

-

22

43

1,564

4,530

3,836

Line of credit

-

-

2,414

-

2,764

3,438

3,510

4,137

2,000

2,000

-

0

-

-

-

-

-

-

-

-

0

0

-

6,000

6,000

7,996

2,989

2,871

Term note

-

-

6,000

-

6,000

6,000

6,000

6,000

0

0

0

2,000

2,000

2,000

1,833

1,333

833

333

-

0

-

-

-

-

-

-

-

-

Convertible note, net

2,273

3,101

2,778

2,481

2,302

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Advance, current

-

1,500

1,500

-

1,500

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other derivatives

0

0

55

86

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Current liabilities of discontinuing operations

3,229

22,665

-

20,742

-

-

221

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total current liabilities

12,675

31,908

28,319

28,179

28,339

21,542

20,722

19,640

11,694

9,111

8,760

11,046

10,620

10,127

10,344

9,865

6,504

4,832

4,080

4,366

5,286

2,372

2,457

8,619

8,077

12,638

13,102

11,771

Obligations under operating leases, less current portion

29

78

1,542

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Obligations under finance leases, less current portion

148

140

294

-

-

-

-

624

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred rent payable and other

-

-

-

-

-

-

-

360

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Term note

-

-

-

-

-

-

-

-

4,936

4,838

4,779

2,654

3,151

3,648

4,146

4,642

5,138

5,635

-

0

-

-

-

-

-

-

-

-

Obligations under finance leases, less current portion

-

-

-

23

451

564

641

-

726

687

616

374

228

242

251

276

254

269

285

300

322

331

309

309

-

-

-

7

Advance from siParadigm, less current portion

505

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred rent payable and other

0

0

0

154

283

304

324

-

181

207

229

290

299

306

309

315

289

310

330

348

152

157

167

170

169

167

165

164

Notes payable, Long-Term

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,148

2,440

Line of credit

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

6,000

6,000

6,000

6,000

6,000

0

-

-

6,000

6,000

Warrant liability

15

49

255

248

1,122

1,134

3,711

4,403

4,167

7,043

7,620

2,018

2,814

0

0

17

34

248

67

52

-

-

-

594

1,178

518

7,518

12,549

Deferred revenue, long-term

-

-

403

-

442

547

-

429

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

145

274

513

-

-

-

-

-

Acquisition note payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

657

961

634

560

767

-

-

0

-

-

-

-

Deferred revenue, long-term

-

-

-

-

-

-

992

-

1,130

438

436

428

864

753

622

752

782

799

825

925

936

-

-

0

-

-

-

-

Total Liabilities

13,372

32,175

30,813

28,604

30,637

24,091

26,390

25,456

22,834

22,324

22,440

16,810

17,976

15,076

15,672

15,867

13,661

13,056

12,222

12,551

13,611

9,136

9,448

9,694

9,424

13,324

28,934

32,933

STOCKHOLDERS’ EQUITY
Preferred stock, authorized 9,764 shares, $0.0001 par value, none issued

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

-

-

-

-

-

Common stock, authorized 100,000 shares, $0.0001 par value, 2,101 and 924 shares issued and outstanding at September 30, 2019 and December 31, 2018, respectively

0

6

6

0

3

3

3

3

2

2

2

2

2

2

1

1

0

0

0

1

0

0

0

0

0

0

0

0

Additional paid-in capital

171,696

171,021

170,022

164,458

163,092

162,575

161,801

161,527

158,068

144,923

144,457

139,576

139,023

136,590

131,701

131,167

114,754

113,996

113,216

112,520

110,814

108,459

107,444

106,786

63,681

48,864

25,067

24,970

Accumulated other comprehensive income (loss)

-101

19

-16

60

104

134

49

69

-1

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Treasury stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

17

Accumulated deficit

-164,131

-166,106

-162,333

-157,716

-153,951

-145,432

-141,799

-134,834

-126,933

-126,300

-123,534

-113,954

-111,178

-107,433

-103,405

-98,151

-92,437

-87,225

-82,245

-77,967

-72,794

-67,997

-63,810

-61,324

-58,800

-55,733

-46,591

-48,934

Stockholders' Equity Attributable to Parent

7,464

4,940

7,679

6,802

9,248

17,280

20,054

26,765

31,136

18,625

20,925

25,624

27,847

29,159

28,297

33,017

22,318

26,771

30,971

34,554

38,021

40,463

43,635

45,463

4,881

-6,868

-21,523

-23,981

Total Liabilities and Stockholders’ Equity

20,836

37,115

38,492

35,406

39,885

41,371

46,444

52,221

53,970

40,949

43,365

42,434

45,823

44,235

43,969

48,884

35,979

39,827

43,194

47,105

51,633

49,599

53,083

55,157

14,306

6,455

7,410

8,951

NovellusDx, Ltd
Advance, current

1,500

-

-

535

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

siParadigm
Advance, current

469

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-